Evolutionary pathways of transmitted drug-resistant HIV-1.
about
Patterns of transmitted HIV drug resistance in Europe vary by risk groupGenotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National SurveyTime trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational studyEvolutionary dynamics of HIV at multiple spatial and temporal scales.HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptationTen years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008-2011In vitro evolution of an HIV integrase binding protein from a library of C-terminal domain γS-crystallin variants.Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic.Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing.Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.Transmitted Drug Resistance among People Living with HIV/Aids at Major Cities of Sao Paulo State, Brazil.Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis.Persistence of HIV-1 transmitted drug resistance mutations.Estimation of the HIV-1 backward mutation rate from transmitted drug-resistant strains.Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.Systematic review of HIV drug resistance in Southeast Asia.Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland.HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance.Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain.Diminished transmission of drug resistant HIV-1 variants with reduced replication capacity in a human transmission model.Prevalence and circulation patterns of variant, atypical and resistant HIV in Los Angeles County (2007-2009).Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecksCharacterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge.Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.Reversing resistance: different routes and common themes across pathogens.Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.Genetic diversity and molecular epidemiology of HIV transmission
P2860
Q28537726-E81151CC-91DC-432B-8FC5-8802C363D5D2Q28543775-F928A2FF-77E9-4DE5-B147-FF70720C4BF0Q28554729-A42E9352-0B3F-408C-86E6-B045DD501829Q28728325-EDF06135-08C9-4C3B-B638-3F5D44919150Q30416280-C511C733-FB1B-4BEB-B6D2-E22E6824C923Q33699581-A78E6960-9B55-425C-8472-23AF356388F1Q33828355-84F0DF0B-D26E-420E-A7B8-9174A69DA48FQ34283967-52E72CA0-DF71-4512-9DDD-F4FDC530B6D8Q34363222-63686674-3727-4368-B88A-D1DA815FDA83Q34469240-8FF2E682-200B-484D-A5F0-646737B87927Q34677368-C633DF6F-5D8F-4B42-9390-359DD8B7510BQ34819651-D3B5495F-3121-400E-952C-3D7548FCD1B5Q36255602-834625DB-9C4E-416F-B373-60319D662853Q36284159-93FA7C67-D2F4-4580-AD5A-09DD17C007C3Q36406860-ED561D45-6493-4970-9A6D-73078A3E022EQ36582418-88AA82B7-0E7F-49CA-9D6A-EA3BB6A7CD73Q37112617-0CE9EF5A-D138-4B3F-B8FE-2F5E7E30052DQ37213028-B7944A09-C716-461E-98CA-45C26BA8FE38Q37447287-60B96108-23C3-49FB-B9D5-CA622D78D20DQ37494332-6B8D21EA-6B79-4C99-8A95-BC4D8922359FQ37639245-0E87B2E5-87A9-4410-B81D-D475E3F6F577Q37643256-12373E9A-33E5-425F-B7E3-5DC26B0DFC70Q37913478-1E97453C-CA48-42D3-AA9E-82B3AE469713Q38543385-11AAD30A-9CA7-4EC3-A0D3-DCC95630A8D4Q38703935-86ED0E58-983E-4252-95EA-093A3FD7D388Q39289633-F7158E8F-67BC-4B3D-A603-3D6AC8EB3DA1Q40280080-F5F18AA2-DD59-426A-A6DC-8FF574AEF6DAQ40944825-4F54133F-515E-42FF-9392-AE60ACC4D2E0Q41603336-02AA1539-B9F1-41BC-9123-1AD80EC5E365Q42209331-73C057C7-1BFB-4270-875E-99D63C5876E6Q42577298-99D7FE67-6F8E-48A4-8A8A-78EF490C4BCBQ47140686-9D4B75E6-AE1C-4300-9036-E60F46C58A6FQ50145794-BFF379CC-9A35-4400-B5FF-A7AD4887C4C4Q51314844-D5122496-2C6F-4551-9F33-BFADC0B63BDFQ53724442-82F92638-B8E3-4582-85A9-2701DF4C24FBQ54482814-0B453FAD-3277-4939-8FCF-580D67B1752EQ57196807-208A6FB2-79F1-443C-BA35-8CEA1673483C
P2860
Evolutionary pathways of transmitted drug-resistant HIV-1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evolutionary pathways of transmitted drug-resistant HIV-1.
@en
Evolutionary pathways of transmitted drug-resistant HIV-1.
@nl
type
label
Evolutionary pathways of transmitted drug-resistant HIV-1.
@en
Evolutionary pathways of transmitted drug-resistant HIV-1.
@nl
prefLabel
Evolutionary pathways of transmitted drug-resistant HIV-1.
@en
Evolutionary pathways of transmitted drug-resistant HIV-1.
@nl
P2093
P2860
P356
P1476
Evolutionary pathways of transmitted drug-resistant HIV-1
@en
P2093
Annemarie M J Wensing
Charles A B Boucher
Johan A de Bruijn
Monique Nijhuis
P2860
P304
P356
10.1093/JAC/DKR157
P407
P577
2011-04-18T00:00:00Z